BASi Research Products
Private Company
Funding information not available
Overview
BASi Research Products, founded in 1974 and now a key product division of Inotiv (NOTV), has established itself as a leader in innovative preclinical research tools. Its mission is to empower drug discovery through technologies that automate and refine in vivo sampling, allowing researchers to obtain superior longitudinal data while reducing animal use and experimental variability. The company's strategy leverages its integration within Inotiv's full-service CRO to offer bundled product-service solutions, targeting growth within the expanding preclinical research market driven by increased R&D investment and a regulatory focus on animal welfare.
Technology Platform
Developer of the Culex® Automated Sampling Systems for hands-off fluid collection in conscious rodents and Open Flow Microperfusion (OFM) technology for superior interstitial fluid sampling of large molecules, both designed to refine animal research and improve data quality.
Opportunities
Risk Factors
Competitive Landscape
BASi faces direct competition from firms like DILLER Instruments in automated sampling and Harvard Bioscience/M Dialysis in microdialysis. Its key differentiators are its superior OFM technology for macromolecule recovery, deep integration with a major CRO (Inotiv), and a strong value proposition aligned with the ethical 3Rs framework.